Pathophysiological targets in OA therapy.
D018014:Gene Transfer Techniques / Q000592:standards; D006801:Humans; D008666:Metalloendopeptidases / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D010003:Osteoarthritis / Q000378:metabolism / Q000628:therapy*; D018121:Receptors, Cytokine / Q000627:therapeutic use